Why the study?
Does myocardial T2 mapping correlate with laboratory markers of myocardial injury in patients with hypertrophic cardiomyopathy?
Does myocardial T2 mapping correlate with laboratory markers of myocardial injury in patients with hypertrophic cardiomyopathy?
Myocardial T2 mapping can identify myocardial injury in patients with hypertrophic cardiomyopathy, correlating with elevated troponin T and BNP levels.
T2 mapping may aid myocardial injury detection in HCM; leaves open its diagnostic role and clinical utility.
OBJECTIVE: The aim of this study was to evaluate the usefulness of T2 mapping for detecting myocardial injuries in patients with hypertrophic cardiomyopathy (HCM). METHODS: Twenty-one HCM patients and 7 healthy volunteers were examined. The T2 values were measured at hyperintense areas (high-T2 areas) identified with T2 mapping, at late gadolinium enhancement (LGE) areas, and in nullified myocardium of the HCM patients. The associations between T2 values and laboratory data or LGE areas were assessed. RESULTS: High-T2 areas had significantly greater T2 values than LGE areas (P < 0.05) and nullified areas (P < 0.01) of HCM and normal myocardium (P < 0.01). The presence of high-T2 areas was associated with an increase in troponin T levels (P = 0.02), and T2 values correlated with the levels of brain natriuretic peptide (P = 0.036, r = 0.86). CONCLUSIONS: T2 mapping identified myocardial injuries suggested by the laboratory data in HCM.
No takes yet. Share an insight, caveat, or question.
Amano et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: